Organisation paid for research Program year 2021 Source: CMS Open Payments

US Oncology Specialty LP McKesson

Neither a doctor nor a teaching hospital

Research payments

$788,752

17 payments

Through program year 2021, US Oncology Specialty LP McKesson is reported as receiving $788,752 in research payments, across 17 payments.

By program year

3 rows
Year Kind Amount Payments
2021 Research $357,300 6
2020 Research $21,612 2
2019 Research $409,840 9

Breakdown

Who paid Research payments · program years 2019–2021
  1. Merck Sharp & Dohme Corporation $788,752 17 payments
Studies the money was for Research payments · program years 2019–2021
  1. Investigating incurable,unresectable, recurrent or metastatic cutaneous Squamous Cell Carcinoma r,m cSCC and unresectable, locoregionally advanced cutaneous Squamous Cell Carcinoma LA cSCC eligible for palliative systemic treatment cutaneous Squamous Cell Carcinoma cSCC patient population in the community oncology setting including treatment patterns and outcomes. $273,295 6 payments
  2. Treatment Patterns in Patients with Small Cell Lung Cancer $156,900 3 payments
  3. Real-World Treatment Patterns in Patients with Advanced Gastric,Gastroesphogageal Junction GEJ Cancers $133,900 2 payments
  4. Assess real-world utilization of systemic therapies intravenous and oral chemotherapies, targeted therapies and immunotherapies and outcomes in incurable,unresectable r,m cSCC and unresectable LA cSCC eligible for palliative systemic treatment patients. $83,295 1 payment
  5. Investigating incurable,unresectable, recurrent or metastatic cutaneous Squamous Cell Carcinoma and unresectable, locoregionally advanced cutaneous Squamous Cell Carcinoma eligible for palliative systemic treatment cutaneous Squamous Cell Carcinoma patient population in the community oncology setting including treatment patterns and outcomes. $71,112 3 payments
  6. Real-World Treatment Patterns in Patients with Advanced Gastric,Gastroesphogageal Junction , GEJ Cancers $66,500 1 payment
  7. This is a retrospective observational study to examine patient characteristics, treatment patterns and outcomes among patients with incurable,unresectable r,m cSCC and unresectable LA cSCC eligible for palliative systemic treatment $3,750 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record